Cargando…
Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
INTRODUCTION: Viral suppression prevents HIV transmission and disease progression, but socio-economic and clinical factors can hinder the goal of suppression. We evaluated factors associated with viral non suppression (VNS) and persistent viremia (PV) in people living with HIV (PLHIV) receiving anti...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554948/ https://www.ncbi.nlm.nih.gov/pubmed/34706742 http://dx.doi.org/10.1186/s12981-021-00400-9 |
_version_ | 1784591885722976256 |
---|---|
author | Ortíz, Dean W. Roberts-Sano, Olivia Marroquin, Hugo E. Larson, Lindsey Franco, Katherine B. Spec, Andrej Melendez, Johanna R. Pinzón, Rodolfo Samayoa, Ana J. Mejia-Chew, Carlos O´Halloran, Jane A. |
author_facet | Ortíz, Dean W. Roberts-Sano, Olivia Marroquin, Hugo E. Larson, Lindsey Franco, Katherine B. Spec, Andrej Melendez, Johanna R. Pinzón, Rodolfo Samayoa, Ana J. Mejia-Chew, Carlos O´Halloran, Jane A. |
author_sort | Ortíz, Dean W. |
collection | PubMed |
description | INTRODUCTION: Viral suppression prevents HIV transmission and disease progression, but socio-economic and clinical factors can hinder the goal of suppression. We evaluated factors associated with viral non suppression (VNS) and persistent viremia (PV) in people living with HIV (PLHIV) receiving antiretroviral therapy (ART) in Guatemala. METHODS: We conducted a cross sectional analysis using data from an ongoing cohort of PLHIV attending the largest HIV clinic in Guatemala. Univariable and multivariable analyses were conducted between PLHIV with viral suppression and detectable viremia. VNS was defined as most recent HIV RNA ≥ 200 copies/ml and PV as two consecutive HIV RNA ≥ 200 copies/ml. RESULTS: Of 664 participants, 13.3% had VNS and 7.1% had PV. In univariable analysis disaggregated by gender, low income, poor education, perceived difficulty attending healthcare, and alcohol use were associated with VNS in men while low CD4 at diagnosis, multiple prior ART regimens and treatment interruptions were significant in both genders. Multiple prior ART regimens (adjusted Odds Ratio (aOR) 2.82, [95% confidence interval (CI) 1.59, 4.99], p < 0.01), treatment interruptions (aOR 4.51, [95% CI 2.13, 9.58], p < 0.01), excessive alcohol consumption (aOR 2.56, [95% CI 1.18, 5.54], p < 0.05) perceived difficulty attending healthcare (aOR 2.07, [ 95% CI 1.25, 3.42], p < 0.01) and low CD4 at diagnosis (aOR 2.34, 95% [CI 1.30, 4.20], p < 0.01) were independently associated with VNS on multivariable regression. CONCLUSIONS: We conclude that socio-economic and clinical factors influence viral suppression in our cohort and vary between men and women. Gender specific approaches are necessary to achieve the 90% suppression goal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-021-00400-9. |
format | Online Article Text |
id | pubmed-8554948 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85549482021-10-29 Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala Ortíz, Dean W. Roberts-Sano, Olivia Marroquin, Hugo E. Larson, Lindsey Franco, Katherine B. Spec, Andrej Melendez, Johanna R. Pinzón, Rodolfo Samayoa, Ana J. Mejia-Chew, Carlos O´Halloran, Jane A. AIDS Res Ther Research INTRODUCTION: Viral suppression prevents HIV transmission and disease progression, but socio-economic and clinical factors can hinder the goal of suppression. We evaluated factors associated with viral non suppression (VNS) and persistent viremia (PV) in people living with HIV (PLHIV) receiving antiretroviral therapy (ART) in Guatemala. METHODS: We conducted a cross sectional analysis using data from an ongoing cohort of PLHIV attending the largest HIV clinic in Guatemala. Univariable and multivariable analyses were conducted between PLHIV with viral suppression and detectable viremia. VNS was defined as most recent HIV RNA ≥ 200 copies/ml and PV as two consecutive HIV RNA ≥ 200 copies/ml. RESULTS: Of 664 participants, 13.3% had VNS and 7.1% had PV. In univariable analysis disaggregated by gender, low income, poor education, perceived difficulty attending healthcare, and alcohol use were associated with VNS in men while low CD4 at diagnosis, multiple prior ART regimens and treatment interruptions were significant in both genders. Multiple prior ART regimens (adjusted Odds Ratio (aOR) 2.82, [95% confidence interval (CI) 1.59, 4.99], p < 0.01), treatment interruptions (aOR 4.51, [95% CI 2.13, 9.58], p < 0.01), excessive alcohol consumption (aOR 2.56, [95% CI 1.18, 5.54], p < 0.05) perceived difficulty attending healthcare (aOR 2.07, [ 95% CI 1.25, 3.42], p < 0.01) and low CD4 at diagnosis (aOR 2.34, 95% [CI 1.30, 4.20], p < 0.01) were independently associated with VNS on multivariable regression. CONCLUSIONS: We conclude that socio-economic and clinical factors influence viral suppression in our cohort and vary between men and women. Gender specific approaches are necessary to achieve the 90% suppression goal. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12981-021-00400-9. BioMed Central 2021-10-27 /pmc/articles/PMC8554948/ /pubmed/34706742 http://dx.doi.org/10.1186/s12981-021-00400-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ortíz, Dean W. Roberts-Sano, Olivia Marroquin, Hugo E. Larson, Lindsey Franco, Katherine B. Spec, Andrej Melendez, Johanna R. Pinzón, Rodolfo Samayoa, Ana J. Mejia-Chew, Carlos O´Halloran, Jane A. Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala |
title | Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala |
title_full | Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala |
title_fullStr | Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala |
title_full_unstemmed | Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala |
title_short | Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala |
title_sort | factors associated with viremia in people living with hiv on antiretroviral therapy in guatemala |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554948/ https://www.ncbi.nlm.nih.gov/pubmed/34706742 http://dx.doi.org/10.1186/s12981-021-00400-9 |
work_keys_str_mv | AT ortizdeanw factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT robertssanoolivia factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT marroquinhugoe factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT larsonlindsey factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT francokatherineb factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT specandrej factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT melendezjohannar factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT pinzonrodolfo factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT samayoaanaj factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT mejiachewcarlos factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala AT ohalloranjanea factorsassociatedwithviremiainpeoplelivingwithhivonantiretroviraltherapyinguatemala |